LKtime's cell line development platform includes stable cell line development, cell bank production and cell line stability research based on mature CHO and 293 cells, which can provide clients with high-quality and comprehensive cell line development services for monoclonal antibodies, bispecific / multi-specific antibodies, fusion proteins, enzymes and recombinant vaccines.

- CLD services can be customized based on product characteristics.

- The top1 clone from GOI can be provided within 3-4 months at the earliest.

- A variety of commercial host cells with clear backgrounds and complete information have been introduced to support development and commercialization use license.

- Client-specified host cells are also accepted.

- The cell bank production process records meet the requirements of NMPA and FDA.

- Complete monoclonal origin certification materials can be provided.

- Metabolic screening markers (glutamine synthetase, dihydrofolate reductase) and antibiotic screening markers (zeocin, blasticidin, puromycin, G418, etc.) can be provided for serving the clients.